AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether Fludarabine in combination with cytarabine
is more effective than high-dose cytarabine in post-remission therapy for patients with
AML1-ETO acute myeloid leukemia.